Literature DB >> 25548487

HIF-1α induces VE-cadherin expression and modulates vasculogenic mimicry in esophageal carcinoma cells.

Na-Na Tang1, Hong Zhu1, Hong-Jie Zhang1, Wei-Feng Zhang1, Hai-Lin Jin1, Lu Wang1, Pin Wang1, Gui-Jun He1, Bo Hao1, Rui-Hua Shi1.   

Abstract

AIM: To investigate whether hypoxia inducible factor (HIF)-1α modulates vasculogenic mimicry (VM) by upregulating VE-cadherin expression in esophageal squamous cell carcinoma (ESCC).
METHODS: Esophageal squamous cancer cell lines Eca109 and TE13 were transfected with plasmids harboring small interfering RNAs targeting HIF-1α or VE-cadherin. The proliferation and invasion of esophageal carcinoma cells were detected by MTT and Transwell migration assays. The formation of tubular networks of cells was analyzed by 3D culture in vitro. BALB/c nude mice were used to observe xenograft tumor formation. The relationship between the expression of HIF-1α and VE-cadherin, ephrinA2 (EphA2) and laminin5γ2 (LN5γ2) was measured by Western blot and real-time polymerase chain reaction.
RESULTS: Knockdown of HIF-1α inhibited cell proliferation (32.3% ± 6.1% for Eca109 cells and 38.6% ± 6.8% for TE13 cells, P < 0.05). Both Eca109 and TE13 cells formed typical tubular networks. The number of tubular networks markedly decreased when HIF-1α or VE-cadherin was knocked down. Expression of VE-cadherin, EphA2 and LN5γ2 was dramatically inhibited, but the expression of matrix metalloproteinase 2 had no obvious change in HIF-1α-silenced cells. Knockdown of VE-cadherin significantly decreased expression of both EphA2 and LN5γ2 (P < 0.05), while HIF-1α expression was unchanged. The time for xenograft tumor formation was 6 ± 1.2 d for Eca109 cells and Eca109 cells transfected with HIF-1α Neo control short hairpin RNA (shRNA) vector, and 8.4 ± 2.1 d for Eca109 cells transfected with an shRNA against HIF-1α. Knockdown of HIF-1α inhibited vasculogenic mimicry (VM) and tumorigenicity in vivo.
CONCLUSION: HIF-1α may modulate VM in ESCC by regulating VE-cadherin expression, which affects VM formation through EphA2 and LN5γ2.

Entities:  

Keywords:  Esophageal squamous cell carcinoma; Hypoxia-inducible factor-1α; RNA interference; VE-cadherin; Vasculogenic mimicry

Mesh:

Substances:

Year:  2014        PMID: 25548487      PMCID: PMC4273139          DOI: 10.3748/wjg.v20.i47.17894

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  37 in total

Review 1.  Hypoxic microenvironment as a cradle for melanoma development and progression.

Authors:  Carmen Z Michaylira; Hiroshi Nakagawa
Journal:  Cancer Biol Ther       Date:  2006-05-26       Impact factor: 4.742

2.  [Relationship between vasculogenic mimicry and clinical pathological characters in retinoblastoma].

Authors:  Ying-jun Niu; Fu-ling Liu; Ying Yang; Chun-yan Yuan
Journal:  Zhonghua Yan Ke Za Zhi       Date:  2009-04

3.  Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry.

Authors:  A J Maniotis; R Folberg; A Hess; E A Seftor; L M Gardner; J Pe'er; J M Trent; P S Meltzer; M J Hendrix
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

4.  Expression and functional significance of Twist1 in hepatocellular carcinoma: its role in vasculogenic mimicry.

Authors:  Tao Sun; Nan Zhao; Xiu-Lan Zhao; Qiang Gu; Shi-Wu Zhang; Na Che; Xing-Hui Wang; Jing Du; Yi-Xin Liu; Bao-Cun Sun
Journal:  Hepatology       Date:  2010-02       Impact factor: 17.425

5.  Prognostic role of vasculogenic mimicry in colorectal cancer.

Authors:  Coen I M Baeten; Femke Hillen; Patrick Pauwels; Adriaan P de Bruine; Cor G M I Baeten
Journal:  Dis Colon Rectum       Date:  2009-12       Impact factor: 4.585

6.  Excess glucose induces hypoxia-inducible factor-1α in pancreatic cancer cells and stimulates glucose metabolism and cell migration.

Authors:  Zhiwen Liu; Xiaohui Jia; Yijie Duan; Huijie Xiao; Karl-Gösta Sundqvist; Johan Permert; Feng Wang
Journal:  Cancer Biol Ther       Date:  2013-02-01       Impact factor: 4.742

7.  VE-cadherin regulates EphA2 in aggressive melanoma cells through a novel signaling pathway: implications for vasculogenic mimicry.

Authors:  Angela R Hess; Elisabeth A Seftor; Lynn M Gruman; Michael S Kinch; Richard E B Seftor; Mary J C Hendrix
Journal:  Cancer Biol Ther       Date:  2006-02-14       Impact factor: 4.742

8.  Prognostic significance of periodic acid-Schiff-positive patterns in clear cell renal cell carcinoma.

Authors:  Amalia A Vartanian; Eugenia V Stepanova; Sergey L Gutorov; Elico Sh Solomko; Irina N Grigorieva; Irina N Sokolova; Anatoly Yu Baryshnikov; Mikhail R Lichinitser
Journal:  Can J Urol       Date:  2009-08       Impact factor: 1.344

Review 9.  Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions.

Authors:  Ji-Won Lee; Seong-Hui Bae; Joo-Won Jeong; Se-Hee Kim; Kyu-Won Kim
Journal:  Exp Mol Med       Date:  2004-02-29       Impact factor: 8.718

10.  HIF-1α knockdown by miRNA decreases survivin expression and inhibits A549 cell growth in vitro and in vivo.

Authors:  Wei Li; Yu-Qing Chen; Yuan-Bing Shen; Hong-Mei Shu; Xiao-Jing Wang; Cheng-Ling Zhao; Chang-Jie Chen
Journal:  Int J Mol Med       Date:  2013-06-04       Impact factor: 4.101

View more
  32 in total

1.  [Biejiajian Pills inhibits hepatoma carcinoma cell vasculogenic mimicry by suppressing RhoA/ROCK signaling pathway].

Authors:  Haiyan An; Junhao Lin; Haitao Sun; Lili Xu; Jiaqi Su; Chunyu He; Jiamin Zeng; Peixiang Liang; Songqi He
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-07-30

2.  Fenretinide reduces angiogenesis by downregulating CDH5, FOXM1 and eNOS genes and suppressing microRNA-10b.

Authors:  Elif Isil Yücel; Mehmet Sahin
Journal:  Mol Biol Rep       Date:  2020-01-10       Impact factor: 2.316

3.  The effect of hepatocellular carcinoma-associated fibroblasts on hepatoma vasculogenic mimicry.

Authors:  Qin She; Shuya Hu; Xia Pu; Qingxi Guo; Chunru Mou; Chengwan Yang
Journal:  Am J Cancer Res       Date:  2020-12-01       Impact factor: 6.166

4.  Clinical significance of vasculogenic mimicry, vascular endothelial cadherin and SOX4 in patients with esophageal squamous cell carcinoma.

Authors:  Yanzi Qin; Wenjun Zhao; Lili Cheng; Shiwu Wu; Qiong Wu; Jin Gao; Zhaonan Bian; Li Ma
Journal:  Int J Clin Exp Pathol       Date:  2019-07-01

Review 5.  Vascular mimicry: Triggers, molecular interactions and in vivo models.

Authors:  Stephen L Wechman; Luni Emdad; Devanand Sarkar; Swadesh K Das; Paul B Fisher
Journal:  Adv Cancer Res       Date:  2020-07-16       Impact factor: 6.242

Review 6.  Physicochemical aspects of the tumour microenvironment as drivers of vasculogenic mimicry.

Authors:  Elena Andreucci; Silvia Peppicelli; Jessica Ruzzolini; Francesca Bianchini; Lido Calorini
Journal:  Cancer Metastasis Rev       Date:  2022-10-13       Impact factor: 9.237

Review 7.  Vascular mimicry: changing the therapeutic paradigms in cancer.

Authors:  Nazila Fathi Maroufi; Sina Taefehshokr; Mohammad-Reza Rashidi; Nima Taefehshokr; Mahdieh Khoshakhlagh; Alireza Isazadeh; Narmin Mokarizadeh; Behzad Baradaran; Mohammad Nouri
Journal:  Mol Biol Rep       Date:  2020-05-18       Impact factor: 2.316

Review 8.  The tumour immune microenvironment in oesophageal cancer.

Authors:  Maria Davern; Noel E Donlon; Margaret R Dunne; Robert Power; Conall Hayes; Ross King; John V Reynolds
Journal:  Br J Cancer       Date:  2021-04-26       Impact factor: 7.640

Review 9.  Hypoxia and its impact on the tumour microenvironment of gastroesophageal cancers.

Authors:  Ross King; Conall Hayes; Claire L Donohoe; Margaret R Dunne; Maria Davern; Noel E Donlon
Journal:  World J Gastrointest Oncol       Date:  2021-05-15

10.  Destruction of vasculogenic mimicry channels by targeting epirubicin plus celecoxib liposomes in treatment of brain glioma.

Authors:  Rui-Jun Ju; Fan Zeng; Lei Liu; Li-Min Mu; Hong-Jun Xie; Yao Zhao; Yan Yan; Jia-Shuan Wu; Ying-Jie Hu; Wan-Liang Lu
Journal:  Int J Nanomedicine       Date:  2016-03-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.